Trump Pushes Fast-Track For Psychedelic Drug, Orders to Speed Up Research, Approval Timeline for PTSD

Trump ordered faster approval of ibogaine for PTSD, backing research and funding that could expand access to ...

FDA approves first drug for rare kidney scarring disease

Sparsentan, sold as Filspari, will be available for nephrologists to prescribe immediately to patients with FSGS ...
Stocktwits on MSN

CMPS stock surges as White House psychedelic push prompts FDA review, boosts COMP360 prospects

The order calls on the FDA to give priority to select psychedelic treatments that have demonstrated positive results in ...
Indiana Daily StudentOpinion

OPINION: The FDA plans to review psilocybin-assisted therapy. Let’s review the facts

Despite this, the Food and Drug Administration didn’t formally review a psychedelic compound for federal regulation until ...
PharmTech

What Sparsentan's FDA Approval Means for Rare Kidney Disease

Full FDA approval covers proteinuria reduction in FSGS without nephrotic syndrome, a defined clinical subset differentiated ...
Medical News Today

FDA approves Wegovy-like GLP-1 pill, Foundayo, for weight loss

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...

FDA Approval Process for Medical Devices Course: How to Make the Most of the FDA Pre-submission Process (June 30, 2026 and July 1, 2026)

The course offers key opportunities in understanding U.S. medical device approval pathways, including 510(k), IDE, PMA, and De Novo. It enhances practical skills through interactive case studies and ...
The Scientist

New FDA Policies for Faster Drug Reviews Met with Mixed Reactions

In July 2025, the US Food and Drug Administration (FDA) announced a pilot program intended to expedite reviews for drug applications that met one of five national priorities, including products deemed ...